State of Wyoming’s ADMA Biologics ADMA Stock Holding History

State of Wyoming’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Sell	16,927 -44,051	-72%	-$402K	0.01%	1229
2026 Q1	$549K	Buy	60,978 +25,744	+73%	+$406K	0.07%	271
2025 Q4	$643K	Buy	+35,234	New	+$594K	0.07%	253
2025 Q2	–	Sell	-9,545	Closed	-$189K	–	1840
2025 Q1	$189K	Buy	+9,545	New	+$165K	0.03%	836
2024 Q4	–	Sell	-8,761	Closed	-$175K	–	1591
2024 Q3	$175K	Sell	8,761 -23,693	-73%	-$368K	0.03%	798
2024 Q2	$363K	Sell	32,454 -7,389	-19%	-$62K	0.06%	228
2024 Q1	$263K	Sell	39,843 -12,541	-24%	-$68.5K	0.04%	422
2023 Q4	$237K	Buy	52,384 +42,785	+446%	+$158K	0.04%	451
2023 Q3	$34.4K	Sell	9,599 -4,620	-32%	-$17.8K	0.01%	1352
2023 Q2	$52.5K	Sell	14,219 -26,895	-65%	-$99.7K	0.02%	1140
2023 Q1	$136K	Buy	+41,114	New	+$142K	0.04%	588
2022 Q1	–	Sell	-11,679	Closed	-$16K	–	1769
2021 Q4	$16K	Buy	+11,679	New	+$15.4K	0.01%	1555

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State of Wyoming's ADMA Position: Q2 2026 in Review

State of Wyoming reduced its ADMA Biologics (ADMA) stake by 72% in Q2 2026, selling an estimated $402K and leaving 16,927 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #1229.

State of Wyoming first reported a position in ADMA in Q4 2021 and has held it in 12 quarters since. The position peaked at $643K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

State of Wyoming held 16,927 shares of ADMA Biologics worth $142K as of Q2 2026.
State of Wyoming sold 44,051 ADMA Biologics shares in Q2 2026, an estimated $402K.
ADMA Biologics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1229 holding.
State of Wyoming first reported a position in ADMA Biologics in Q4 2021 and has held it in 12 quarters since.
State of Wyoming's ADMA Biologics position peaked at $643K in Q4 2025.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.